Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
132M
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
91.5M
-
Shares change
-
+63.8M
-
Total reported value, excl. options
-
$145M
-
Value change
-
+$101M
-
Number of buys
-
48
-
Number of sells
-
-28
-
Price
-
$1.59
Significant Holders of FRACTYL HEALTH, INC. - Class A Common Stock (GUTS) as of Q3 2025
89 filings reported holding GUTS - FRACTYL HEALTH, INC. - Class A Common Stock as of Q3 2025.
FRACTYL HEALTH, INC. - Class A Common Stock (GUTS) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91.5M shares
of 132M outstanding shares and own 69.21% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (12.1M shares), SILVERARC CAPITAL MANAGEMENT, LLC (10.6M shares), Alyeska Investment Group, L.P. (5.65M shares), Woodline Partners LP (5.51M shares), Catalio Capital Management, LP (5.21M shares), Rosalind Advisors, Inc. (5M shares), General Catalyst Group Management, LLC (4.88M shares), Deer Management Co. LLC (4.77M shares), HCC Manager LLC (4.67M shares), and 683 Capital Management, LLC (4.65M shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.